Journal of General Virology, Vol 78, 3009-3018, Copyright © 1997 by Society for General Microbiology

ARTICLES

Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis

AM Sanchez-Perez, S Soriano, AR Clarke and K Gaston
Department of Biochemistry, School of Medical Sciences, University of Bristol, UK.

Human papillomavirus type 16 (HPV-16) is a DNA tumour virus that has been implicated in the development of cervical cancer. In non- transformed HPV-infected cells, the HPV E2 protein regulates transcription of the viral E6 and E7 oncogenes. Malignant transformation is usually accompanied by disruption of the E2 gene and consequent deregulated expression of E6 and E7. Here we show that re- introduction of the HPV-16 E2 protein into an HPV-16-transformed cervical carcinoma cell line results in a decrease in growth rate and, in the absence of serum growth factors, cell death via apoptosis. E2 expression increases E6/E7 mRNA levels. This brings about an increase in E7 protein levels, which in turn leads to an increase in free E2F, a condition that has previously been shown to induce apoptotic cell death. Despite the increase in E6 mRNA there is no detectable E6 protein in these cells and E2 expression does not reduce the activity of a p53-responsive promoter. Our data suggest that disruption of the E2 gene produces HPV-transformed cells that are less liable to undergo apoptosis and, therefore, more likely to form cervical tumours.

This article has been cited by other articles:

				S. Mole, S. G. Milligan, and S. V. Graham Human Papillomavirus Type 16 E2 Protein Transcriptionally Activates the Promoter of a Key Cellular Splicing Factor, SF2/ASF J. Virol., January 1, 2009; 83(1): 357 - 367. [Abstract] [Full Text] [PDF]

				M. L. Nguyen, R. M. Kraft, M. Aubert, E. Goodwin, D. DiMaio, and J. A. Blaho p53 and hTERT Determine Sensitivity to Viral Apoptosis J. Virol., December 1, 2007; 81(23): 12985 - 12995. [Abstract] [Full Text] [PDF]

				J. L. Parish, A. Kowalczyk, H.-T. Chen, G. E. Roeder, R. Sessions, M. Buckle, and K. Gaston E2 Proteins from High- and Low-Risk Human Papillomavirus Types Differ in Their Ability To Bind p53 and Induce Apoptotic Cell Death J. Virol., May 1, 2006; 80(9): 4580 - 4590. [Abstract] [Full Text] [PDF]

				H. M. Zhang, J. Yuan, P. Cheung, D. Chau, B. W. Wong, B. M. McManus, and D. Yang Gamma Interferon-Inducible Protein 10 Induces HeLa Cell Apoptosis through a p53-Dependent Pathway Initiated by Suppression of Human Papillomavirus Type 18 E6 and E7 Expression Mol. Cell. Biol., July 15, 2005; 25(14): 6247 - 6258. [Abstract] [Full Text] [PDF]

				R. M. Ordonez, A. M. Espinosa, D. J. Sanchez-Gonzalez, J. Armendariz-Borunda, and J. Berumen Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription J. Gen. Virol., June 1, 2004; 85(6): 1433 - 1444. [Abstract] [Full Text] [PDF]

				S. M. Horner, R. A. DeFilippis, L. Manuelidis, and D. DiMaio Repression of the Human Papillomavirus E6 Gene Initiates p53-Dependent, Telomerase-Independent Senescence and Apoptosis in HeLa Cervical Carcinoma Cells J. Virol., April 15, 2004; 78(8): 4063 - 4073. [Abstract] [Full Text] [PDF]

				G Gallo, M Bibbo, L Bagella, A Zamparelli, F Sanseverino, M R Giovagnoli, A Vecchione, and A Giordano Study of viral integration of HPV-16 in young patients with LSIL J. Clin. Pathol., July 1, 2003; 56(7): 532 - 536. [Abstract] [Full Text] [PDF]

				T Kinjo, K Kamiyama, K Chinen, T Iwamasa, K Kurihara, and T Hamada Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells Mol. Pathol., April 1, 2003; 56(2): 97 - 108. [Abstract] [Full Text] [PDF]

				R. A. DeFilippis, E. C. Goodwin, L. Wu, and D. DiMaio Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma Cells J. Virol., December 20, 2002; 77(2): 1551 - 1563. [Abstract] [Full Text] [PDF]

				D. Kanduc Translational Regulation of Human Papillomavirus Type 16 E7 mRNA by the Peptide SEQIKA, Shared by Rabbit {alpha}1-Globin and Human Cytokeratin 7 J. Virol., June 14, 2002; 76(14): 7040 - 7048. [Abstract] [Full Text] [PDF]

				K. Webster, A. Taylor, and K. Gaston Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins J. Gen. Virol., January 1, 2001; 82(1): 201 - 213. [Abstract] [Full Text]

				E. C. Goodwin and D. DiMaio Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways PNAS, November 7, 2000; 97(23): 12513 - 12518. [Abstract] [Full Text] [PDF]

				K. Webster, J. Parish, M. Pandya, P. L. Stern, A. R. Clarke, and K. Gaston The Human Papillomavirus (HPV) 16 E2 Protein Induces Apoptosis in the Absence of Other HPV Proteins and via a p53-dependent Pathway J. Biol. Chem., January 7, 2000; 275(1): 87 - 94. [Abstract] [Full Text] [PDF]

				H. Lewis, K. Webster, A.-M. Sanchez-Perez, and K. Gaston Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein J. Gen. Virol., August 1, 1999; 80(8): 2087 - 2096. [Abstract] [Full Text]

				L. K. Naeger, E. C. Goodwin, E.-S. Hwang, R. A. DeFilippis, H. Zhang, and D. DiMaio Bovine Papillomavirus E2 Protein Activates a Complex Growth-inhibitory Program in p53-negative HT-3 Cervical Carcinoma Cells that Includes Repression of Cyclin A and cdc25A Phosphatase Genes and Accumulation of Hypophosphorylated Retinoblastoma Protein Cell Growth Differ., June 1, 1999; 10(6): 413 - 422. [Abstract] [Full Text]